Q linea Strong ASTar results presented at AMCLI - Marketscreener.com
| QLINEA Stock | SEK 1.08 0.01 0.92% |
About 61% of Q Linea's investor base is looking to short. The analysis of current outlook of investing in Q linea AB suggests that many traders are alarmed regarding Q Linea's prospects. The current market sentiment, together with Q Linea's historical and current headlines, can help investors time the market. In addition, many technical investors use Q linea AB stock news signals to limit their universe of possible portfolio assets.
QLINEA |
Q linea Strong ASTar results presented at AMCLI Marketscreener.com
Read at news.google.com
 |
Q Linea Fundamental Analysis
We analyze Q Linea's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Q Linea using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Q Linea based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Q Linea is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Q linea AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Q Linea stock to make a market-neutral strategy. Peer analysis of Q Linea could also be used in its relative valuation, which is a method of valuing Q Linea by comparing valuation metrics with similar companies.
Peers
Q Linea Related Equities
| HNSA | Hansa Biopharma | 0.59 | ||||
| CAMX | Camurus AB | 0.18 | ||||
| BONEX | Bonesupport Holding | 1.26 | ||||
| IMMNOV | Immunovia Publ | 5.26 |
Complementary Tools for QLINEA Stock analysis
When running Q Linea's price analysis, check to measure Q Linea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q Linea is operating at the current time. Most of Q Linea's value examination focuses on studying past and present price action to predict the probability of Q Linea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q Linea's price. Additionally, you may evaluate how the addition of Q Linea to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |